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Schlüsselwörter
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Zusammenfassung
Hintergrund: Übelkeit und Erbrechen sind häufige Symp-
tome bei Patienten mit fortgeschrittenen Tumorerkran-
kungen. Verschiedene, manchmal seltene Ursachen müs-
sen bedacht werden, bevor die richtige Therapie gewählt
werden kann. Fallbericht: Wir berichten über eine Patien-
tin mit fortgeschrittenem metastasiertem Mammakarzi-
nom, die über mehrere Wochen unter therapieresistenter
Übelkeit und Erbrechen litt. Später entwickelte sie eine
deutliche Hyperpigmentierung der Haut und eine hy-
poosmolare Dehydratation. In der computertomographi-
schen Untersuchung des Abdomens war eine Vergröße-
rung der Nebennieren zu sehen. Die Verdachtsdiagnose
einer Nebenniereninsuffizienz aufgrund von Nebennie-
renmetastasen wurde durch Labortests bestätigt. Unter
Substitutionstherapie mit Hydrocortison und Fludrocorti-
son verbesserte sich der Allgemeinzustand der Patientin
dramatisch, Übelkeit und Erbrechen verschwanden kom-
plett. Schlussfolgerung: Eine Nebenniereninsuffizienz
sollte bei Patienten mit einer fortgeschrittenen Tumorer-
krankung und ungeklärter und protrahierter Übelkeit, Er-
brechen und Schwäche, besonders in Verbindung mit
einer Hyponatriämie und normalen Kaliumwerten, ver-
mutet werden.
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Summary
Background: Nausea and vomiting are common symp-
toms in patients with malignant disease. Several, some-
times rare causes have to be considered to decide the
right treatment. Case Report: We report of a patient suf-
fering from advanced breast cancer and complaining of
severe nausea and vomiting over several weeks without
any successful treatment. Later on, she developed
marked hyperpigmentation of the skin and hypo-osmolar
dehydration. Adrenal enlargement was noted in an ab-
dominal scan. The suspected diagnosis of primary
adrenocortical insufficiency due to metastases was con-
firmed by laboratory tests. After replacement therapy
with hydrocortisone and fludrocortisone, the general
condition of the patient improved dramatically and the
symptoms of nausea and vomiting disappeared com-
pletely. Conclusion: If a patient with advanced cancer
presents with unexplained and protracted nausea, vomit-
ing and weakness, particularly if accompanied by hy-
ponatremia and normal potassium levels, adrenal insuf-
ficiency due to adrenal metastases should be considered.
Introduction
Nausea and vomiting are common symptoms in patients with
advanced metastatic malignancy [1]. There are several causes
for nausea and vomiting, mainly gastrointestinal, metabolic,
toxic, cerebral and psychological [2]. However, some rare
causes of nausea and vomiting can easily be overlooked, with
the consequence that adequate treatment will not be provid-
ed. We report of a 75-year-old lady suffering from profuse
nausea and vomiting.
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Case Report
A 75-year-old lady with metastatic breast cancer and known bone metas-
tases was admitted to our palliative care unit in February 2005 with per-
sistent nausea, profuse vomiting and signs of dehydration. After breast
surgery in 1996, she had received adjuvant chemotherapy and radiothera-
py. In summer 2004, she had received oral cyclophosphamide for several
months to treat newly developed bone metastases. On admission, we saw
a very ill lady with marked weakness, who needed support to leave her
bed. On physical examination, she presented with low blood pressure
(85/65 mm Hg), marked dehydration and hyperpigmentation of the skin,
predominantly in the face (fig. 1). The patient had noticed a change in
her skin color for several months.
In November 2004, she had been admitted to a department of gastroen-
terology where she had presented with profuse nausea and vomiting for
the first time. At that time, low blood pressure (110/70 mm Hg) and dehy-
dration were the only remarkable signs on physical examination. The rel-
evant laboratory findings are shown in table 1. Computed tomography
(CT) examination of the brain, gastroscopy and abdominal ultrasound
showed no relevant abnormalities. The chest X-ray showed a marked
right-sided pleural effusion. The patient recovered after rehydration and
antiemetic therapy with metoclopramide and was discharged. In January
2005, the patient was re-admitted to the hospital, again complaining of
nausea and severe vomiting. She had not taken antiemetics at home as
they did not help. This time, she presented in bad general physical condi-
tion with exhaustion, weakness and dizziness. Her blood pressure was
85/65 mm Hg. Physical examination was without pathological findings, ex-
cept for reduced respiratory sounds over the right lung. The relevant lab-
oratory findings are shown in table 1. The brain CT scan was repeated
without showing new results. A CT scan of the thorax showed the known
pleural effusion and pathological tissue below the carina and in proximity
of the right bronchus. An abdominal CT scan showed a liver cyst in the
left lobe, plump adrenal glands and widespread bone metastases (fig. 2).
The patient was again rehydrated and treated with metoclopramide. After
2 weeks, her condition improved and she was discharged.
The laboratory findings in February 2005 showed hypo-osmolar dehydra-
tion with severe hyponatremia but relatively high potassium levels despite
continuous vomiting (table 1). These findings, together with the adrenal
enlargement noted on the abdominal CT scan, suggested a diagnosis of
adrenal metastases causing primary adrenocortical insufficiency. To con-
firm the diagnosis, the basal serum cortisol levels were measured which
were close to the lower limit of the normal range, while the level of
adrenocorticotropic hormone (ACTH) was elevated 60-fold. An ACTH
stimulation test failed to show a rise in serum cortisol levels (table 1). The
patient was initially treated with intravenous hydrocortisone 200 mg, fol-
lowed by oral hydrocortisone 20 mg daily and fludrocortisone 0.1 mg
daily. The general condition of the patient improved dramatically within
days, and the symptoms of nausea and vomiting disappeared completely.
Discussion
Adrenal metastases are not often detected in metastatic can-
cer. In a recent study from Hong Kong, the prevalence of
adrenal metastases at post-mortem examination, adrenalecto-
my and fine needle aspiration biopsy in 464 cancer patients
was 3.1% [3]. The main primary cancers metastasizing into the
adrenal glands were lung cancer (35.4%) and gastrointestinal
cancers (stomach 14.3%, esophagus 12.1%, liver/bile ducts
10.7%). In this study, breast malignancy was the primary site
in only 2.9% of cases.
Corresponding with the low incidence of adrenal metastases,
clinical findings of adrenal insufficiency confirmed by labora-
tory tests have been reported only infrequently in cancer pa-
tients. In addition, the prevalence of adrenal insufficiency ap-
pears low even in patients with bilateral adrenal metastases
[4]. Less than 100 cases of confirmed adrenal insufficiency due
to local metastases have been published [3], only a few of
which concerned breast cancer patients. Davi et al. [5] report-
ed of a patient in whom adrenal involvement became clinical-
ly evident 20 years after radical mastectomy as the only sec-
ondary localization of the tumor. Sheeler et al. [6] presented 
4 cases (1 breast cancer) where adrenal insufficiency was diag-
nosed at the time of the initial diagnosis of the tumor or at oc-
currence of first metastases. However, adrenal insufficiency is
quite common in patients with breast cancer who are treated
with medroxyprogesterone acetate or megestrol acetate. Both
drugs have cortisol-like effects with subsequent suppression at
the hypothalamic level. In these patients, ACTH levels are low
Fig. 1. Photograph
taken in February
2005 showing skin
hyperpigmentation.
Fig. 2. Abdominal
CT scan showing
bilateral adrenal
metastases (arrows).
hyperpigmentation.
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[7]. On the other hand, adrenal insufficiency is often suspected
in cancer patients as fatigue, weakness, nausea and vomiting
are common symptoms in advanced stages. Cedermark et al.
[8] evaluated the adrenal activity of 39 patients with dissemi-
nated carcinoma but without metastases to the adrenal glands.
Of those, 15 patients showed clinical signs and symptoms of
adrenal insufficiency. However, cortisol secretion was found
to be increased rather than decreased in these patients, proba-
bly due to stress. The authors concluded that symptoms re-
sembling adrenal insufficiency in cancer patients are not usu-
ally associated with decreased cortisol secretion.
In conclusion, if a patient with advanced cancer presents with
unexplained and protracted nausea, vomiting and weakness,
adrenal insufficiency should be considered, particularly if ac-
companied by hyponatremia and normal potassium levels.
Our patient had been suffering from severe nausea and vomit-
ing together with fatigue and adynamia for over 3 months.
After exclusion of the main possible causes, e.g. hepatomegaly,
brain metastases, hypercalcemia or drug side effects, primary
adrenal insufficiency due to bilateral adrenal metastases was
found to be the cause of the symptoms. We did not confirm
the diagnosis histologically, as it would not have had any con-
sequence. Therefore, it remains unclear whether the metas-
tases were caused by the breast cancer or possibly lung cancer
which could be suspected in connection with the findings of
the chest CT scan. Lastly, treatment of adrenal insufficiency in
patients with metastatic malignant disease greatly increases
quality of life and improves life expectancy.
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Clinical chemistry (normal levels) Laboratory results

6th December 4th January 10/11th Fe-
2004 2005 bruary 2005
Sodium, mmol/l (135–145 mmol/l) 130.0 125.0 113.0 
Potassium, mmol/l (3.5–5.0 mmol/l) 4.7 5.0 5.0 
Calcium, mmol/l (2.05–2.65 mmol/l) 2.43 2.51 2.36 
Glucose, mmol/l (3.88–6.38 mmol/l) 4.93 4.38 2.55 
Plasma cortisol, basal, mg/dl (5–25 µg/dl) 5.4 
Plasma cortisol after ACTH stimulation, µg/dl 5.7 
(more than double the basal level)
ACTH, pg/ml (10–50 pg/ml) >1,499 
Table 1. Laboratory findings
